A 12 week, open, randomized, parallel, multicenter study of efficacy, tolerability and safety of hydrochlorothiazide (+) losartan potassium versus amlodipine in essential hypertensive patients

Trial Profile

A 12 week, open, randomized, parallel, multicenter study of efficacy, tolerability and safety of hydrochlorothiazide (+) losartan potassium versus amlodipine in essential hypertensive patients

Completed
Phase of Trial: Phase IV

Latest Information Update: 19 Apr 2017

At a glance

  • Drugs Amlodipine (Primary) ; Losartan/hydrochlorothiazide (Primary)
  • Indications Essential hypertension
  • Focus Therapeutic Use
  • Sponsors Merck & Co
  • Most Recent Events

    • 01 Feb 2007 Status changed from in progress.
    • 05 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top